What's in Watson Laboratories, Inc.'s pipeline?

Watson Laboratories, Inc. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Watson Laboratories, Inc.'s portfolio?

Top competitors by shared drug class: B. Braun Medical SA, GWT-TUD GmbH, GlaxoSmithKline, Padagis LLC, Sanofi.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/watson-laboratories-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Watson Laboratories, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Watson Laboratories, Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Clindamycin Phosphate / Benzoyl Peroxide Gel	Clindamycin Phosphate / Benzoyl Peroxide Gel	phase 3	Topical antibiotic combination	Bacterial ribosome (clindamycin); oxidative antimicrobial mechanism (benzoyl peroxide)	Dermatology

Therapeutic area mix

Dermatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

B. Braun Medical SA · 1 shared drug class
GWT-TUD GmbH · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Padagis LLC · 1 shared drug class
Sanofi · 1 shared drug class
Stiefel, a GSK Company · 1 shared drug class
Sun Pharmaceutical Industries, Inc. · 1 shared drug class
University Health Network, Toronto · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Watson Laboratories, Inc.:

Cite this brief

Drug Landscape (2026). Watson Laboratories, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/watson-laboratories-inc. Accessed 2026-05-17.